DE69106110D1 - Kosmetische Verwendung eines Mittels gegen Erytheme. - Google Patents

Kosmetische Verwendung eines Mittels gegen Erytheme.

Info

Publication number
DE69106110D1
DE69106110D1 DE69106110T DE69106110T DE69106110D1 DE 69106110 D1 DE69106110 D1 DE 69106110D1 DE 69106110 T DE69106110 T DE 69106110T DE 69106110 T DE69106110 T DE 69106110T DE 69106110 D1 DE69106110 D1 DE 69106110D1
Authority
DE
Germany
Prior art keywords
erythema
remedy
cosmetic use
nadp
nad
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69106110T
Other languages
English (en)
Other versions
DE69106110T2 (de
Inventor
Paolo Giacomoni
Jean-Luc Morancais
Alain Lety
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LOreal SA
Original Assignee
LOreal SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LOreal SA filed Critical LOreal SA
Application granted granted Critical
Publication of DE69106110D1 publication Critical patent/DE69106110D1/de
Publication of DE69106110T2 publication Critical patent/DE69106110T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A61Q17/04Topical preparations for affording protection against sunlight or other radiation; Topical sun tanning preparations

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Birds (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
DE69106110T 1990-10-30 1991-10-22 Kosmetische Verwendung eines Mittels gegen Erytheme. Expired - Fee Related DE69106110T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9013437A FR2668366B1 (fr) 1990-10-30 1990-10-30 Utilisation cosmetique d'une composition ayant une activite antierythemale et composition correspondante.

Publications (2)

Publication Number Publication Date
DE69106110D1 true DE69106110D1 (de) 1995-02-02
DE69106110T2 DE69106110T2 (de) 1995-08-10

Family

ID=9401699

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69106110T Expired - Fee Related DE69106110T2 (de) 1990-10-30 1991-10-22 Kosmetische Verwendung eines Mittels gegen Erytheme.

Country Status (8)

Country Link
US (1) US5250290A (de)
EP (1) EP0484199B1 (de)
JP (1) JP3489082B2 (de)
AT (1) ATE115856T1 (de)
CA (1) CA2054475A1 (de)
DE (1) DE69106110T2 (de)
ES (1) ES2065647T3 (de)
FR (1) FR2668366B1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5470577A (en) * 1993-07-07 1995-11-28 Trustees Of Boston University Stimulation of tanning by DNA fragments or single-stranded DNA
US5690944A (en) * 1994-12-20 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing lactate dehydrogenase inhibitors
DE19545107A1 (de) * 1995-12-04 1997-06-05 Beiersdorf Ag Verwendung eines wirksamen Gehaltes an Adenosin in kosmetischen oder dermatologischen Zubereitungen
ATE244254T1 (de) * 1996-02-16 2003-07-15 Max Planck Gesellschaft Phosphatidyloligoglycerine
DE19622224A1 (de) 1996-02-16 1997-08-21 Max Planck Gesellschaft Phosphatidyloligoglycerine
DE19723778A1 (de) * 1997-06-06 1998-12-10 Beiersdorf Ag Kosmetische und dermatologische Lichtschutzformulierungen mit einem Gehalt an Triazinderivaten und Mono-Di- und/oder Trialkylestern der Phosphorsäure
US20020006913A1 (en) 1997-11-04 2002-01-17 Von Borstel Reid W. Antimutagenic compositions for treatment and prevention of photodamage to skin
ATE273008T1 (de) 1998-12-01 2004-08-15 Univ Kentucky Res Found Verwendung von nikotinsäurederivate zur behandlung von dna-schäden bei hautzellen
ATE359060T1 (de) * 2000-11-22 2007-05-15 Otsuka Pharma Co Ltd Öl-in-wasser-emulsionszusammensetzung und verfahren zu ihrer herstellung
US20070183995A1 (en) * 2006-02-09 2007-08-09 Conopco, Inc., D/B/A Unilever Compounds useful as agonists of A2A adenosine receptors, cosmetic compositions with A2A agonists and a method for using the same
JP2008094813A (ja) * 2006-10-16 2008-04-24 Naris Cosmetics Co Ltd 抗老化皮膚組成物
US7842725B2 (en) 2008-07-24 2010-11-30 Ecolab USA, Inc. Foaming alcohol compositions with selected dimethicone surfactants
CN105497055B (zh) * 2014-09-24 2018-05-08 上海交通大学 烟酰胺腺嘌呤二核苷酸在制备防治皮肤辐射损伤药物中的应用
US9730867B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Methods of forming a slurry with microcapsules formed from phosphate esters
US9732303B2 (en) 2016-01-06 2017-08-15 The Procter & Gamble Company Microcapsules formed from phosphate esters and compositions containing same
US10154947B2 (en) 2016-01-06 2018-12-18 The Procter & Gamble Company Antiperspirant composition

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2597367B1 (fr) * 1986-04-22 1988-07-15 Oreal Procede pour faciliter la formation de spherules lipidiques en dispersion dans une phase aqueuse et pour ameliorer leur stabilite et leur taux d'encapsulation, et dispersions correspondantes.
EP0256472A3 (de) * 1986-08-11 1988-09-07 Lion Corporation Kosmetische Mittel zur Anwendung auf der Haut
US4767741A (en) * 1986-08-15 1988-08-30 Avon Products, Inc. Two-phase liquid cosmetic and method of preparing same
JPH075477B2 (ja) * 1988-12-28 1995-01-25 テルモ株式会社 ヘモグロビン含有リポソームおよびその製法
US5073296A (en) * 1990-04-17 1991-12-17 Isp Investments Inc. Preparation of discrete microdroplets of an oil in water
US5063057A (en) * 1990-09-26 1991-11-05 Elizabeth Arden Co., Division Of Conopco, Inc. Cosmetic capsules
US5082661A (en) * 1990-09-26 1992-01-21 Elizabeth Arden Co., Division Of Conopco, Inc. Odorless cosmetic compositions in gelatin capsules

Also Published As

Publication number Publication date
JPH0624953A (ja) 1994-02-01
DE69106110T2 (de) 1995-08-10
FR2668366A1 (fr) 1992-04-30
ES2065647T3 (es) 1995-02-16
FR2668366B1 (fr) 1993-01-29
US5250290A (en) 1993-10-05
CA2054475A1 (fr) 1992-05-01
ATE115856T1 (de) 1995-01-15
EP0484199B1 (de) 1994-12-21
JP3489082B2 (ja) 2004-01-19
EP0484199A1 (de) 1992-05-06

Similar Documents

Publication Publication Date Title
DE69106110D1 (de) Kosmetische Verwendung eines Mittels gegen Erytheme.
BR9508779A (pt) Derivados de rodamina fototivávies uso dos mesmos e processos para terapia fotodinâmica de um paciente e para purga in vitro de medula óssea
ATE170741T1 (de) Verwendung eines antagonisten der substanz p in einer kosmetischen zusammensetzung und erhaltene zusammensetzung
FI945838A (fi) Ektoiini ja ektoiinijohdannaiset kosteuttavina aineina kosmetiikkatuotteissa
DE69902131D1 (de) Kosmetische und/oder dermatologische Zusammensetzung enthaltend Salicylsäure oder ihre Derivate und ihre Verwendung
DE69629721D1 (de) Carnamoyloxy derivate von mutilin und deren verwendung als antibakterielles mittels
ATE186207T1 (de) Haarfärbemittel
ATE124388T1 (de) Kosmetische zusammensetzungen.
AU674142B2 (en) Use of cosmetic composition
ATE221376T1 (de) Verwendung von nmifa als entzündungshemmer in oberflächlichem saugetier-gewebe
DK0565519T3 (da) Illudinanaloge som antitumormidler
EP0197358A3 (en) Topical use of 3-phenylacetylamino-2,6-piperidinedione for treatment of skin wrinkles and hyperpigmentation
NO174801C (de)
EP0277641A3 (de) Kosmetik
ATE126058T1 (de) Dermatologische zusammensetzungen mit einem gehalt an cis-urocaninsäure.
DE69322252D1 (de) Formulierung und verwendung von carotenoiden in der krebsbehandlung
DE59811094D1 (de) Hautschutzzubereitung
FI920906A0 (fi) Foerfaranden foer foerebyggande och minskande av aerrskador.
IT9021768A0 (it) Derivato della melatonina ad attivita' terapeutica in dermatologia
DE29706458U1 (de) Ascorbinsäure als Adjuvans in der Chemo- und Strahlentherapie von Malignomen
DE69013972D1 (de) Kosmetische Zusammensetzung.
ATE70440T1 (de) Verwendung von anipamil als artereosklerosemittel.
ATE54413T1 (de) In der dermatologie anwendbare und imidazolidinylurea als aktiven grundbestandteil enthaltende therapeutische zusammensetzung.
ATE302591T1 (de) Kosmetische oder dermatologische lichtschutzzubereitungen mit einem gehalt an dioctylbutamidotriazon und einem oder mehreren polyolen
ATE189809T1 (de) Antiarrhytmische (s)-enantiomere von methansulphonamiden

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee